4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-25-000085
10% owner sold 62,743 shares at an average $13.89 ($871,709)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2025-02-10 | Sale | −42,987 | $13.95 | $599,669 | 3,332,473 | I |
| Saba Capital Management, L.P. 10% owner | 2025-02-11 | Sale | −19,756 | $13.77 | $272,040 | 3,312,717 | I |
| Open-market sales · 62,743 sh · avg $13.89 · $871,709 | |||||||
Loading xslF345X05/primary_doc.xml…